Sputnik V: International Success, Domestic Problems
Sputnik V, Russia's COVID-19 vaccine, is not just a scientific achievement but a golden moment for vaccine diplomacy. Despite the initial distrust — some of which persists — dozens of countries have granted Sputnik V emergency use authorization. Why is Russia falling behind in its domestic vaccination campaign, and will Russia be able to maintain its international vaccine leadership?
The Kennan Institute's Maxim Trudolyubov discusses Sputnik V with Olga Dobrovidova, one of Russia’s leading science and environment journalists, and Judy Twigg, a professor of political science at Virginia Commonwealth University and expert on global health and Russian politics.
Correction: At the time of this conversation, Hungary and Slovakia had purchased the Sputnik V vaccine, while the Czech Republic had only expressed interest.
The Kennan Institute is the premier U.S. center for advanced research on Russia and Eurasia and the oldest and largest regional program at the Woodrow Wilson International Center for Scholars. The Kennan Institute is committed to improving American understanding of Russia, Ukraine, and the region through research and exchange. Read more